SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Guang-Ning Yan, Yang-Fan Lv, Qiao-Nan Guo, Advances in osteosarcoma stem cell research and opportunities for novel therapeutic targets, Cancer Letters, 2016, 370, 2, 268

    CrossRef

  2. 2
    Fei Dai, Sisi Yang, Fei Zhang, Dongwen Shi, Zehua Zhang, Jun Wu, Jianzhong Xu, hTERT- and hCTLA4Ig-expressing human bone marrow-derived mesenchymal stem cells: in vitro and in vivo characterization and osteogenic differentiation, Journal of Tissue Engineering and Regenerative Medicine, 2016, 10, 5
  3. 3
    Shilian Zhang, Yuehua Zhao, Lijie Wang, MicroRNA-198 inhibited tumorous behaviors of human osteosarcoma through directly targeting ROCK1, Biochemical and Biophysical Research Communications, 2016, 472, 3, 557

    CrossRef

  4. 4
    Sara R. Martins-Neves, Willem E. Corver, Daniela I. Paiva-Oliveira, Brendy E. W. M. van den Akker, Inge H. Briaire-de-Bruijn, Judith V. M. G. Bovée, Célia M. F. Gomes, Anne-Marie Cleton-Jansen, Osteosarcoma Stem Cells Have Active Wnt/β-catenin and Overexpress SOX2 and KLF4, Journal of Cellular Physiology, 2016, 231, 4
  5. 5
    Gabriela Silva, Abdelilah Aboussekhra, p16INK4A inhibits the pro-metastatic potentials of osteosarcoma cells through targeting the ERK pathway and TGF-β1, Molecular Carcinogenesis, 2016, 55, 5
  6. 6
    George Jour, Lu Wang, Sumit Middha, Ahmet Zehir, Wen Chen, Justyna Sadowska, John Healey, Narasimhan P Agaram, Lisa Choi, Khedoudja Nafa, Meera Hameed, The molecular landscape of extraskeletal osteosarcoma: A clinicopathological and molecular biomarker study, The Journal of Pathology: Clinical Research, 2016, 2, 1
  7. 7
    C. Tieken, M. C. Verboom, W. Ruf, H. Gelderblom, J. V. M. G. Bovée, P. H. Reitsma, A.-M. Cleton-Jansen, H. H. Versteeg, Tissue factor associates with survival and regulates tumour progression in osteosarcoma, Thrombosis and Haemostasis, 2016, 115, 5, 1025

    CrossRef

  8. 8
    Seon Young Kim, Kyongok Im, Si Nae Park, Jiseok Kwon, Jung-Ah Kim, Qute Choi, Sang Mee Hwang, Sung-Hee Han, Sunghoon Kwon, Il-Hoan Oh, Dong Soon Lee, Asymmetric Aneuploidy in Mesenchymal Stromal Cells Detected by In Situ Karyotyping and Fluorescence In Situ Hybridization: Suggestions for Reference Values for Stem Cells, Stem Cells and Development, 2015, 24, 1, 77

    CrossRef

  9. 9
    Zuzanna Baranski, Tijmen H Booij, Anne-Marie Cleton-Jansen, Leo S Price, Bob van de Water, Judith VMG Bovée, Pancras CW Hogendoorn, Erik HJ Danen, Aven-mediated checkpoint kinase control regulates proliferation and resistance to chemotherapy in conventional osteosarcoma, The Journal of Pathology, 2015, 236, 3
  10. 10
    Philip Savage, Clinical observations on chemotherapy curable malignancies: unique genetic events, frozen development and enduring apoptotic potential, BMC Cancer, 2015, 15, 1, 11

    CrossRef

  11. 11
    Nilesh P. Talele, Julie Fradette, John E. Davies, Andras Kapus, Boris Hinz, Expression of α-Smooth Muscle Actin Determines the Fate of Mesenchymal Stromal Cells, Stem Cell Reports, 2015, 4, 6, 1016

    CrossRef

  12. 12
    Rong Cai, Naoki Kawazoe, Guoping Chen, Influence of surfaces modified with biomimetic extracellular matrices on adhesion and proliferation of mesenchymal stem cells and osteosarcoma cells, Colloids and Surfaces B: Biointerfaces, 2015, 126, 381

    CrossRef

  13. 13
    Emilie P Buddingh, S Eriaty N Ruslan, Christianne M A Reijnders, Karoly Szuhai, Marieke L Kuijjer, Helene Roelofs, Pancras C W Hogendoorn, R Maarten Egeler, Anne-Marie Cleton-Jansen, Arjan C Lankester, Mesenchymal stromal cells of osteosarcoma patients do not show evidence of neoplastic changes during long-term culture, Clinical Sarcoma Research, 2015, 5, 1

    CrossRef

  14. 14
    Valerie B. Sampson, Soonmoon Yoo, Asmita Kumar, Nancy S. Vetter, E. Anders Kolb, MicroRNAs and Potential Targets in Osteosarcoma: Review, Frontiers in Pediatrics, 2015, 3,

    CrossRef

  15. 15
    Makoto Endo, Marieke A de Graaff, Davis R Ingram, Simin Lim, Dina C Lev, Inge H Briaire-de Bruijn, Neeta Somaiah, Judith VMG Bovée, Alexander J Lazar, Torsten O Nielsen, NY-ESO-1 (CTAG1B) expression in mesenchymal tumors, Modern Pathology, 2015, 28, 4, 587

    CrossRef

  16. 16
    Yunlong He, Luis F. de Castro, Min Hwa Shin, Wendy Dubois, Howard H. Yang, Shunlin Jiang, Pravin J. Mishra, Ling Ren, Hongfeng Gou, Ashish Lal, Chand Khanna, Glenn Merlino, Maxwell Lee, Pamela G. Robey, Jing Huang, p53 Loss Increases the Osteogenic Differentiation of Bone Marrow Stromal Cells, STEM CELLS, 2015, 33, 4
  17. 17
    Yongzhao Zhu, Xumei Song, Jian Wang, Yukui Li, Yinxue Yang, Tingting Yang, Haibin Ma, Libin Wang, Guangyi Zhang, William C Cho, Xiaoming Liu, Jun Wei, Placental mesenchymal stem cells of fetal origin deposit epigenetic alterations during long-term culture under serum-free condition, Expert Opinion on Biological Therapy, 2015, 15, 2, 163

    CrossRef

  18. 18
    Bernhard Robl, Chantal Pauli, Sander Martijn Botter, Beata Bode-Lesniewska, Bruno Fuchs, Prognostic value of tumor suppressors in osteosarcoma before and after neoadjuvant chemotherapy, BMC Cancer, 2015, 15, 1

    CrossRef

  19. 19
    Mara Riminucci, Cristina Remoli, Pamela G. Robey, Paolo Bianco, Stem cells and bone diseases: New tools, new perspective, Bone, 2015, 70, 55

    CrossRef

  20. 20
    Gengbin Kong, Zhaoyong Liu, Kezhou Wu, Ying Zhang, Zhihua Deng, Weili Feng, Shubiao Chen, Hu Wang, Strong expression of paired-like homeodomain transcription factor 1 (PITX1) is associated with a favorable outcome in human osteosarcoma, Tumor Biology, 2015, 36, 10, 7735

    CrossRef

  21. 21
    Marcus Tonak, Die Scapula, 2015,

    CrossRef

  22. 22
    Valèrie Trichet, Bone Cancer, 2015,

    CrossRef

  23. 23
    Anne-Marie Cleton-Jansen, Bone Cancer, 2015,

    CrossRef

  24. 24
    Tarja Niini, Sakari Knuutila, Bone Cancer, 2015,

    CrossRef

  25. 25
    Sander M. Botter, Matthias J.E. Arlt, Walter Born, Bruno Fuchs, Bone Cancer, 2015,

    CrossRef

  26. 26
    Liu He, Yong Zheng, Yu Wan, Jian Song, A shorter telomere is the key factor in preventing cultured human mesenchymal stem cells from senescence escape, Histochemistry and Cell Biology, 2014, 142, 3, 257

    CrossRef

  27. 27
    Richard B. Richardson, Age-specific bone tumour incidence rates are governed by stem cell exhaustion influencing the supply and demand of progenitor cells, Mechanisms of Ageing and Development, 2014, 139, 31

    CrossRef

  28. 28
    Anthony J. Mutsaers, Carl R. Walkley, Cells of origin in osteosarcoma: Mesenchymal stem cells or osteoblast committed cells?, Bone, 2014, 62, 56

    CrossRef

  29. 29
    Lei Zhang, Qian Zhou, Ning Zhang, Weixu Li, Meidan Ying, Wan-Jing Ding, Bo Yang, Qiaojun He, E2F1 impairs all-trans retinoic acid-induced osteogenic differentiation of osteosarcoma via promoting ubiquitination-mediated degradation of RARα, Cell Cycle, 2014, 13, 8, 1277

    CrossRef

  30. 30
    L H Chan, W Wang, W Yeung, Y Deng, P Yuan, K K Mak, Hedgehog signaling induces osteosarcoma development through Yap1 and H19 overexpression, Oncogene, 2014, 33, 40, 4857

    CrossRef

  31. 31
    Peter Vrtačnik, Špela Kos, Stephen A. Bustin, Janja Marc, Barbara Ostanek, Influence of trypsinization and alternative procedures for cell preparation before RNA extraction on RNA integrity, Analytical Biochemistry, 2014, 463, 38

    CrossRef

  32. 32
    Sander M Botter, Dario Neri, Bruno Fuchs, Recent advances in osteosarcoma, Current Opinion in Pharmacology, 2014, 16, 15

    CrossRef

  33. 33
    François Lamoureux, Marc Baud’huin, Lidia Rodriguez Calleja, Camille Jacques, Martine Berreur, Françoise Rédini, Fernando Lecanda, James E. Bradner, Dominique Heymann, Benjamin Ory, Selective inhibition of BET bromodomain epigenetic signalling interferes with the bone-associated tumour vicious cycle, Nature Communications, 2014, 5,

    CrossRef

  34. 34
    Sofie LJ Verbeke, Franco Bertoni, Patrizia Bacchini, Jan Oosting, Raf Sciot, Tibor Krenács, Judith VMG Bovée, Active TGF-β signaling and decreased expression of PTEN separates angiosarcoma of bone from its soft tissue counterpart, Modern Pathology, 2013, 26, 9, 1211

    CrossRef

  35. 35
    Marieke L. Kuijjer, Pancras C.W. Hogendoorn, Anne-Marie Cleton-Jansen, Genome-wide analyses on high-grade osteosarcoma: Making sense of a genomically most unstable tumor, International Journal of Cancer, 2013, 133, 11
  36. 36
    Christoph Käcker, Alexander Marx, Katharina Mössinger, Frederike Svehla, Ulrike Schneider, Pancras Cornelis Wilhelmus Hogendoorn, Ole Steen Nielsen, Stefan Küffer, Christian Sauer, Cyril Fisher, Christian Hallermann, Jörg Thomas Hartmann, Jean-Yves Blay, Gunhild Mechtersheimer, Peter Hohenberger, Philipp Ströbel, High frequency of MYC gene amplification is a common feature of radiation-induced sarcomas. Further results from EORTC STBSG TL 01/01, Genes, Chromosomes and Cancer, 2013, 52, 1
  37. 37
    Lei Wang, Yinghua Zhao, Yi Liu, Kentaro Akiyama, Chider Chen, Cunye Qu, Yan Jin, Songtao Shi, IFN-γ and TNF-α Synergistically Induce Mesenchymal Stem Cell Impairment and Tumorigenesis via NFκB Signaling, STEM CELLS, 2013, 31, 7
  38. 38
    Anja Torsvik, Rolf Bjerkvig, Mesenchymal stem cell signaling in cancer progression, Cancer Treatment Reviews, 2013, 39, 2, 180

    CrossRef

  39. 39
    Wei Xiao, Alexander B Mohseny, Pancras C W Hogendoorn, Anne-Marie Cleton-Jansen, Mesenchymal stem cell transformation and sarcoma genesis, Clinical Sarcoma Research, 2013, 3, 1, 10

    CrossRef

  40. 40
    Federica Casiraghi, Giuseppe Remuzzi, Mauro Abbate, Norberto Perico, Multipotent Mesenchymal Stromal Cell Therapy and Risk of Malignancies, Stem Cell Reviews and Reports, 2013, 9, 1, 65

    CrossRef

  41. 41
    Upal Basu-Roy, Claudio Basilico, Alka Mansukhani, Perspectives on cancer stem cells in osteosarcoma, Cancer Letters, 2013, 338, 1, 158

    CrossRef

  42. 42
    Lisbeth Barkholt, Egbert Flory, Veronika Jekerle, Sophie Lucas-Samuel, Peter Ahnert, Louise Bisset, Dirk Büscher, Willem Fibbe, Arnaud Foussat, Marcel Kwa, Olivier Lantz, Romaldas Mačiulaitis, Tiina Palomäki, Christian K. Schneider, Luc Sensebé, Gérard Tachdjian, Karin Tarte, Lucie Tosca, Paula Salmikangas, Risk of tumorigenicity in mesenchymal stromal cell–based therapies—Bridging scientific observations and regulatory viewpoints, Cytotherapy, 2013, 15, 7, 753

    CrossRef

  43. 43
    Kanya Honoki, Toshifumi Tsujiuchi, Senescence bypass in mesenchymal stem cells: a potential pathogenesis and implications of pro-senescence therapy in sarcomas, Expert Review of Anticancer Therapy, 2013, 13, 8, 983

    CrossRef

  44. 44
    J PosthumaDeBoer, S R Piersma, T V Pham, P W van Egmond, J C Knol, A M Cleton-Jansen, M A van Geer, V W van Beusechem, G J L Kaspers, B J van Royen, C R Jiménez, M N Helder, Surface proteomic analysis of osteosarcoma identifies EPHA2 as receptor for targeted drug delivery, British Journal of Cancer, 2013, 109, 8, 2142

    CrossRef

  45. 45
    R Rubio, I Gutierrez-Aranda, A I Sáez-Castillo, A Labarga, M Rosu-Myles, S Gonzalez-Garcia, M L Toribio, P Menendez, R Rodriguez, The differentiation stage of p53-Rb-deficient bone marrow mesenchymal stem cells imposes the phenotype of in vivo sarcoma development, Oncogene, 2013, 32, 41, 4970

    CrossRef

  46. 46
    Haixia Zhang, Haotong Wu, Junheng Zheng, Pei Yu, Lixiao Xu, Pan Jiang, Jin Gao, Hua Wang, Yan Zhang, Transforming Growth Factor β1 Signal is Crucial for Dedifferentiation of Cancer Cells to Cancer Stem Cells in Osteosarcoma, STEM CELLS, 2013, 31, 3
  47. 47
    Jolieke G. van Oosterwijk, Jakob K. Anninga, Hans Gelderblom, Anne-Marie Cleton-Jansen, Judith V.M.G. Bovée, Update on Targets and Novel Treatment Options for High-Grade Osteosarcoma and Chondrosarcoma, Hematology/Oncology Clinics of North America, 2013, 27, 5, 1021

    CrossRef

  48. 48
    Tomohiro Fujiwara, Akira Kawai, Akihiko Yoshida, Toshifumi Ozaki, Takahiro Ochiya, Role of Cancer Stem Cells in Cancer Biology and Therapy, 2013,

    CrossRef

  49. 49
    Karoly Szuhai, Pancras CW Hogendoorn, ‘The chicken or the egg?’ dilemma strikes back for the controlling mechanism in chordoma#, The Journal of Pathology, 2012, 228, 3
  50. 50
    Andrea Y. Angstadt, Venugopal Thayanithy, Subbaya Subramanian, Jaime F. Modiano, Matthew Breen, A genome-wide approach to comparative oncology: high-resolution oligonucleotide aCGH of canine and human osteosarcoma pinpoints shared microaberrations, Cancer Genetics, 2012, 205, 11, 572

    CrossRef

  51. 51
    Magne Skårn, Heidi M. Namløs, Paul Noordhuis, Meng-Yu Wang, Leonardo A. Meza-Zepeda, Ola Myklebost, Adipocyte Differentiation of Human Bone Marrow-Derived Stromal Cells Is Modulated by MicroRNA-155, MicroRNA-221, and MicroRNA-222, Stem Cells and Development, 2012, 21, 6, 873

    CrossRef

  52. 52
    Alexander B Mohseny, Wei Xiao, Ralph Carvalho, Herman P Spaink, Pancras CW Hogendoorn, Anne-Marie Cleton-Jansen, An osteosarcoma zebrafish model implicates Mmp-19 and Ets-1 as well as reduced host immune response in angiogenesis and migration, The Journal of Pathology, 2012, 227, 2
  53. 53
    Carola A.S. Arndt, Peter S. Rose, Andrew L. Folpe, Nadia N. Laack, Common Musculoskeletal Tumors of Childhood and Adolescence, Mayo Clinic Proceedings, 2012, 87, 5, 475

    CrossRef

  54. 54
    Kanya Honoki, Hiromasa Fujii, Yasuaki Tohma, Toshifumi Tsujiuchi, Akira Kido, Shinji Tsukamoto, Toshio Mori, Yasuhito Tanaka, Comparison of Gene Expression Profiling in Sarcomas and Mesenchymal Stem Cells Identifies Tumorigenic Pathways in Chemically Induced Rat Sarcoma Model, ISRN Oncology, 2012, 2012, 1

    CrossRef

  55. 55
    Annemiek M van Maldegem, Aparna Bhosale, Hans J Gelderblom, Pancras CW Hogendoorn, Andrew B Hassan, Comprehensive analysis of published phase I/II clinical trials between 1990-2010 in osteosarcoma and Ewing sarcoma confirms limited outcomes and need for translational investment, Clinical Sarcoma Research, 2012, 2, 1, 5

    CrossRef

  56. 56
    Nitixa Patel, Tilman E. Klassert, Steven J. Greco, Shyam A. Patel, Jessian L. Munoz, Bobby Y. Reddy, Margarette Bryan, Neil Campbell, Natalia Kokorina, Hatem E. Sabaawy, Pranela Rameshwar, Developmental Regulation ofTAC1in Peptidergic-Induced Human Mesenchymal Stem Cells: Implication for Spinal Cord Injury in Zebrafish, Stem Cells and Development, 2012, 21, 2, 308

    CrossRef

  57. 57
    Arjunan Subramanian, Gan Shu-Uin, Ngo Kae-Siang, Kalamegam Gauthaman, Arijit Biswas, Mahesh Choolani, Ariff Bongso, Fong Chui-Yee, Human umbilical cord wharton's jelly mesenchymal stem cells do not transform to tumor-associated fibroblasts in the presence of breast and ovarian cancer cells unlike bone marrow mesenchymal stem cells, Journal of Cellular Biochemistry, 2012, 113, 6
  58. 58
    Marieke L. Kuijjer, Halfdan Rydbeck, Stine H. Kresse, Emilie P. Buddingh, Ana B. Lid, Helene Roelofs, Horst Bürger, Ola Myklebost, Pancras C. W. Hogendoorn, Leonardo A. Meza-Zepeda, Anne-Marie Cleton-Jansen, Identification of osteosarcoma driver genes by integrative analysis of copy number and gene expression data, Genes, Chromosomes and Cancer, 2012, 51, 7
  59. 59
    Rene Rodriguez, Ruth Rubio, Pablo Menendez, Modeling sarcomagenesis using multipotent mesenchymal stem cells, Cell Research, 2012, 22, 1, 62

    CrossRef

  60. 60
    Karoly Szuhai, Anne-Marie Cleton-Jansen, Pancras C.W. Hogendoorn, Judith V.M.G. Bovée, Molecular pathology and its diagnostic use in bone tumors, Cancer Genetics, 2012, 205, 5, 193

    CrossRef

  61. 61
    Emmanuelle David, Franck Tirode, Marc Baud'huin, Pierre Guihard, Karine Laud, Olivier Delattre, Marie F. Heymann, Dominique Heymann, Françoise Redini, Frédéric Blanchard, Oncostatin M Is a Growth Factor for Ewing Sarcoma, The American Journal of Pathology, 2012, 181, 5, 1782

    CrossRef

  62. 62
    Alexander B. Mohseny, Pancras C. W. Hogendoorn, Anne-Marie Cleton-Jansen, Osteosarcoma Models: From Cell Lines to Zebrafish, Sarcoma, 2012, 2012, 1

    CrossRef

  63. 63
    Vincenzo Sollazzo, Marco Galasso, Stefano Volinia, Francesco Carinci, Prion proteins (PRNP and PRND) are over-expressed in osteosarcoma, Journal of Orthopaedic Research, 2012, 30, 6
  64. 64
    Sergey Malchenko, Elisabeth A. Seftor, Yuri Nikolsky, Susan L. Hasegawa, Sean Kuo, Jeff W. Stevens, Stas Poyarkov, Tatiana Nikolskaya, Tamara Kucaba, Min Wang, Hakim Abdulkawy, Thomas Casavant, Jose Morcuende, Joseph Buckwalter, Raymond Hohl, Barry DeYoung, Kemp Kernstine, Maria de Fatima Bonaldo, Mary J. C. Hendrix, Marcelo B. Soares, Vera Maria F. C. Soares, Putative Multifunctional Signature of Lung Metastases in Dedifferentiated Chondrosarcoma, Sarcoma, 2012, 2012, 1

    CrossRef

  65. 65
    Beverly A. Teicher, Searching for molecular targets in sarcoma, Biochemical Pharmacology, 2012, 84, 1, 1

    CrossRef

  66. 66
    Jie Lan, Xiaoguang Liu, Wei Rong, Feng Wei, Liang Jiang, Haiyan Yu, Gengting Dang, Zhongjun Liu, Stro-1+ stromal cells have stem-like features in giant cell tumor of bone, Journal of Surgical Oncology, 2012, 106, 7
  67. 67
    Daniel Zuch, An-Hoa Giang, Yuriy Shapovalov, Edward Schwarz, Randy Rosier, Regis O'Keefe, Roman A. Eliseev, Targeting Radioresistant Osteosarcoma Cells With Parthenolide, Journal of Cellular Biochemistry, 2012, 113, 4
  68. 68
    Alexander B. Mohseny, Yongping Cai, Marieke Kuijjer, Wei Xiao, Brendy van den Akker, Carlos E. de Andrea, Rutger Jacobs, Peter ten Dijke, Pancras C.W. Hogendoorn, Anne-Marie Cleton-Jansen, The activities of Smad and Gli mediated signalling pathways in high-grade conventional osteosarcoma, European Journal of Cancer, 2012, 48, 18, 3429

    CrossRef

  69. 69
    Jeff W. Martin, Jeremy A. Squire, Maria Zielenska, The Genetics of Osteosarcoma, Sarcoma, 2012, 2012, 1

    CrossRef

  70. 70
    Nadia Dani, Martina Olivero, Katia Mareschi, Marjan Maria van Duist, Silvia Miretti, Sara Cuvertino, Salvatore Patanè, Raffaele Calogero, Riccardo Ferracini, Katia Scotlandi, Franca Fagioli, Maria Flavia Di Renzo, The MET oncogene transforms human primary bone-derived cells into osteosarcomas by targeting committed osteo-progenitors, Journal of Bone and Mineral Research, 2012, 27, 6
  71. 71
    Sara R Martins-Neves, Áurio O Lopes, Anália do Carmo, Artur A Paiva, Paulo C Simões, Antero J Abrunhosa, Célia MF Gomes, Therapeutic implications of an enriched cancer stem-like cell population in a human osteosarcoma cell line, BMC Cancer, 2012, 12, 1, 139

    CrossRef

  72. 72
    Sajida Piperdi, Lukas Austin-Page, David Geller, Manpreet Ahluwalia, Sarah Gorlick, Jonathan Gill, Amy Park, Wendong Zhang, Nan Li, So Hak Chung, Richard Gorlick, β-Catenin Does Not Confer Tumorigenicity When Introduced into Partially Transformed Human Mesenchymal Stem Cells, Sarcoma, 2012, 2012, 1

    CrossRef

  73. You have free access to this content73
    Malcolm R Alison, Susan ML Lim, Linda J Nicholson, Cancer stem cells: problems for therapy?, The Journal of Pathology, 2011, 223, 2
  74. 74
    Emilie P. Buddingh, Marco W. Schilham, S. Eriaty N. Ruslan, Dagmar Berghuis, Karoly Szuhai, Jolien Suurmond, Antonie H. M. Taminiau, Hans Gelderblom, R. Maarten Egeler, Massimo Serra, Pancras C. W. Hogendoorn, Arjan C. Lankester, Chemotherapy-resistant osteosarcoma is highly susceptible to IL-15-activated allogeneic and autologous NK cells, Cancer Immunology, Immunotherapy, 2011, 60, 4, 575

    CrossRef

  75. 75
    Alexander B. Mohseny, Pancras C. W. Hogendoorn, Concise Review: Mesenchymal Tumors: When Stem Cells Go Mad, STEM CELLS, 2011, 29, 3
  76. 76
    Emmanuelle David, Pierre Guihard, Bénédicte Brounais, Anne Riet, Céline Charrier, Séverine Battaglia, François Gouin, Stéphanie Ponsolle, Ronan Le Bot, Carl D. Richards, Dominique Heymann, Françoise Rédini, Frédéric Blanchard, Direct anti-cancer effect of oncostatin M on chondrosarcoma, International Journal of Cancer, 2011, 128, 8
  77. 77
    Idriss M Bennani-Baiti, Epigenetic and epigenomic mechanisms shape sarcoma and other mesenchymal tumor pathogenesis, Epigenomics, 2011, 3, 6, 715

    CrossRef

  78. 78
    Alexander B Mohseny, Isidro Machado, Yongping Cai, Karl-Ludwig Schaefer, Massimo Serra, Pancras C W Hogendoorn, Antonio Llombart-Bosch, Anne-Marie Cleton-Jansen, Functional characterization of osteosarcoma cell lines provides representative models to study the human disease, Laboratory Investigation, 2011, 91, 8, 1195

    CrossRef

  79. 79
    Wen Zeng, Rong Wan, Yuehuan Zheng, Shree Ram Singh, Yiyong Wei, Hypoxia, stem cells and bone tumor, Cancer Letters, 2011, 313, 2, 129

    CrossRef

  80. 80
    Piero Picci, Gabriela Sieberova, Marco Alberghini, Alba Balladelli, Daniel Vanel, Pancras C.W. Hogendoorn, Mario Mercuri, Late sarcoma development after curettage and bone grafting of benign bone tumors, European Journal of Radiology, 2011, 77, 1, 19

    CrossRef

  81. 81
    J. H. Healey, Le nuove frontiere della ricerca in oncologia del sistema muscolo-scheletrico, LO SCALPELLO-OTODI Educational, 2011, 25, 3, 173

    CrossRef

  82. 82
    William R Otto, Nicholas A Wright, Mesenchymal stem cells: from experiment to clinic, Fibrogenesis & Tissue Repair, 2011, 4, 1, 20

    CrossRef

  83. 83
    Scott Russinoff, Sara Miran, Ashok L. Gowda, Paul A. Lucas, Osteosarcoma Cells Differentiate into Phenotypes from all Three Dermal Layers, Clinical Orthopaedics and Related Research®, 2011, 469, 10, 2895

    CrossRef

  84. 84
    J. W. Martin, M. Zielenska, G. S. Stein, A. J. van Wijnen, J. A. Squire, The Role of RUNX2 in Osteosarcoma Oncogenesis, Sarcoma, 2011, 2011, 1

    CrossRef

  85. 85
    Uta Kunter, Jürgen Floege, Regenerative Nephrology, 2011,

    CrossRef

  86. 86
    A. S. Grigorian, P. V. Kruglyakov, U. A. Taminkina, O. A. Efimova, A. A. Pendina, A. V. Voskresenskaya, T. V. Kuznetsova, D. G. Polyntsev, Alterations of Cytological and Karyological Profi le of Human Mesenchymal Stem Cells during in Vitro Culturing, Bulletin of Experimental Biology and Medicine, 2010, 150, 1, 125

    CrossRef

  87. 87
    Richard Gorlick, Chand Khanna, Osteosarcoma, Journal of Bone and Mineral Research, 2010, 25, 4
  88. 88
    Alexander B. Mohseny, Chris Tieken, Pieter A. van der Velden, Karoly Szuhai, Carlos de Andrea, Pancras C. W. Hogendoorn, Anne-Marie Cleton-Jansen, Small deletions but not methylation underlie CDKN2A/p16 loss of expression in conventional osteosarcoma, Genes, Chromosomes and Cancer, 2010, 49, 12
  89. 89
    Louis Guillou, Pancras C. W. Hogendoorn, Fred T. Bosman, Soft tissue sarcomas: introduction to the Virchows Archiv review issue, Virchows Archiv, 2010, 456, 2, 107

    CrossRef

  90. 90
    Claire Josse, Renaud Schoemans, Neville-Andrew Niessen, Marie Delgaudine, Anne-Cécile Hellin, Christian Herens, Philippe Delvenne, Vincent Bours, Systematic Chromosomal Aberrations Found in Murine Bone Marrow-Derived Mesenchymal Stem Cells, Stem Cells and Development, 2010, 19, 8, 1167

    CrossRef